Search Results for "New Nexia Biotechnologies 2010"
Original Source: Nexia Biotechnologies Inc
Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (www.pharmathene.com), a privately held biotechnology company focused on the development of biodefense therapeutics, based in Annapolis, Maryland, USA.
Matching Channels
Swine flu is the common name given to a relatively new strain of influenza (flu) that caused a flu pandemic in 2009-2010. It is also referred to as H1N1 influenza (because it is the H1N1 strain of...
Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...
Dyslipidemia is a generally asymptomatic disease in which serum lipid levels deviate from the normal level. It is considered to be a modifiable risk factor for cardiovascular disease due to its dire...
The Top 10 Medical Device Companies
Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in...
Rheumatoid arthritis (RA) is a chronic systemic disease characterized by progressive joint deformity and joint destruction driven by synovial inflammation and hyperplasia in which cytokines play cen...
Matching News
Stellar Biotechnologies develops aquaculture system for KLH manufacturing
Stellar Biotechnologies has developed a controlled, commercial-scale aquaculture system for fully sustainable Keyhole Limpet Hemocyanin (KLH) manufacturing.
PORT HUENEME, CA -- (Marketwire) -- 01/17/13 -- Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of GMP-grad...
PORT HUENEME, CA -- (Marketwire) -- 02/19/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company exceeded its 2012 plan ...
Wilex, Nuclea Biotechnologies form partnership
Pittsfield, Mass-based biomarker pioneer Nuclea Biotechnologies has formed a new long-term partnership with biopharmaceutical company Wilex, which could lead to more effective treatment management for...
BMS pharma deals for oncology biomarkers in collaborative R&D with Adaptive biotechnologies
Bristol-Myers Squibb has entered into a collaborative R&D pharma deals agreement with Adaptive biotechnologies for the discovery of immunological biomarkers in oncology. Under the pharma deals c...
USPTO grants patent to Lifeline Biotechnologies cancer analyzing device
The US Patent and Trademark Office (USPTO) has granted a US Patent NO 8,185,485 B2 to Lifeline Biotechnologies' device used for analyzing thermal data based on breast surface temperature for the detec...
Nuclea Biotechnologies, Inc.: Series B $3.4M
Nuclea Biotechnologies (Pittsfield, MA) a commercial-stage diagnostic company focused on in vitro companion diagnostic assays based on gene and protein expression profiles and biomarkers associated wi...
NanoCarrier's FVIIa alliance hits bump but cisplatin tie-up forges ahead
Around a year after they extended an initial 2010 option and research collaboration, the French state-owned company LFB Biotechnologies and the Japanese bioventure NanoCarrier have temporarily ended...
Matching PubMed Articles
High Throughput Biotechnology in Traditional Fermented Food Industry.
Traditional fermented food is not only the staple food for most of developing countries but also the key healthy food for developed countries. As the healthy function of these foods are gradually disc...
Development and application of biotechnologies in the metal mining industry.
Metal mining faces a number of significant economic and environmental challenges in the twenty-first century for which established and emerging biotechnologies may, at least in part, provide the answe...
Summary of the 9th annual meeting of the Italian Society for Virology.
The 9(th) annual meeting of the Italian Society for Virology (SIV) comprised seven plenary sessions focused on: General virology and viral genetics; Virus-Host interaction and pathogenesis; Viral onco...
A Comparative Pilot Study of Two Dental Implant Metals in a Pig Model.
PURPOSE:: Successful implant treatment is based on implant stability, absence periimplant inflammation, and a functional interface between implant and bone tissue (direct bone-implant contact). The ai...
Efficacy of bendamustine as salvage treatment in an heavily pre-treated Hodgkin lymphoma.
